how bad are glp 1 GLP-1 Medications: Everything You Need to Know What Should I Expect the
Description
Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH
" 1 - 2 " ".
But as the number on the scale drops, health and fitness professionals say many us
Hims &
